11 – 19 of 19
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2014
-
Mark
Svensk medicinsk forskning behöver inte mer styrning
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Assessment of the bone scan index in a randomized placebo-controlled trial of tasquinimod in men with metastatic castration-resistant prostate cancer (mCRPC).
(
- Contribution to journal › Article
- 2013
-
Mark
Bone Scan Index: A prognostic imaging biomarker for high-risk prostate cancer patients receiving primary hormonal therapy
(
- Contribution to journal › Article
-
Mark
Low 25-OH Vitamin D is Associated with Benign Prostatic Hyperplasia
(
- Contribution to journal › Article
- 2012
-
Mark
Inhibition of metastasis in a castration resistant prostate cancer model by the quinoline-3-carboxamide tasquinimod (ABR-215050)
(
- Contribution to journal › Article
-
Mark
The Effect of Baseline Testosterone on the Efficacy of Degarelix and Leuprolide: Further Insights From A 12-Month, Comparative, Phase III Study in Prostate Cancer Patients
(
- Contribution to journal › Article
- 2008
-
Mark
Socialstyrelsens riktlinjer för prostatacancersjukvården. Hälsokontroll med PSA-test--bara för välinformerade män.
(
- Contribution to journal › Article
- 2007
-
Mark
Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005 - Data from the national prostate cancer register in Sweden
(
- Contribution to journal › Article
- 2001
-
Mark
BRCA2 mutation in a family with hereditary prostate cancer
(
- Contribution to journal › Article
- « previous
- 1
- 2
- next »